載入...
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
Novel 2019 coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and coronavirus disease 2019 (COVID-19), the respiratory syndrome it causes, have shaken the world to its core by infecting and claiming the lives of many people since originating in December 2019 in Wuhan, China....
Na minha lista:
| 發表在: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283249/ https://ncbi.nlm.nih.gov/pubmed/33757336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370221999989 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|